Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Total Liabilities: 2010-2025

Historic Total Liabilities for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $560.3 million.

  • BIO-TECHNE's Total Liabilities fell 6.20% to $560.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $560.3 million, marking a year-over-year decrease of 6.20%. This contributed to the annual value of $639.1 million for FY2025, which is 0.64% up from last year.
  • According to the latest figures from Q3 2025, BIO-TECHNE's Total Liabilities is $560.3 million, which was down 12.32% from $639.1 million recorded in Q2 2025.
  • BIO-TECHNE's Total Liabilities' 5-year high stood at $767.2 million during Q4 2023, with a 5-year trough of $536.3 million in Q4 2022.
  • Over the past 3 years, BIO-TECHNE's median Total Liabilities value was $639.1 million (recorded in 2025), while the average stood at $660.3 million.
  • As far as peak fluctuations go, BIO-TECHNE's Total Liabilities dropped by 24.17% in 2021, and later spiked by 43.05% in 2023.
  • Over the past 5 years, BIO-TECHNE's Total Liabilities (Quarterly) stood at $601.9 million in 2021, then decreased by 10.89% to $536.3 million in 2022, then skyrocketed by 43.05% to $767.2 million in 2023, then fell by 22.84% to $591.9 million in 2024, then decreased by 6.20% to $560.3 million in 2025.
  • Its Total Liabilities stands at $560.3 million for Q3 2025, versus $639.1 million for Q2 2025 and $626.2 million for Q1 2025.